期刊文献+

HIV和HCV合并感染对患者外周血中A3GmRNA及干扰素α表达的影响 被引量:1

Impact of HIV/HCV co-infection on peripheral expression of A3G mRNA and interferon-α
原文传递
导出
摘要 目的:研究HIV和HCV(HIV/HCV)感染对患者外周血单个核细胞(PBMC)中A3G mRNA表达及外周血中内源性干扰素( IFN)-α水平的影响。方法以未经抗病毒治疗的慢性丙型肝炎患者( HCV单一感染组,43例)、艾滋病患者( HIV单一感染组, CD4+T 淋巴细胞<200个/μL,45例)和HIV/HCV合并感染组( CD4^+T淋巴细胞<200个/μL,45例)为研究对象,并以23名我院门诊健康体检者作为对照组。采用实时荧光定量PCR法检测A3G mRNA,酶联免疫吸附试验( ELISA)检测血浆中内源性IFN-α的表达量。组间比较采用秩和检验,相关性分析用Spearman秩相关分析。结果 HIV单一感染组、HIV/HCV合并感染组、HCV单一感染组和健康对照组PBMC中A3G mRNA的表达量分别为4.89(0.59),4.85(0.71),3.89(1.08)和3.69(0.81)lg拷贝/mL。其中,HIV单一感染组和HIV/HCV合并感染组PBMC中A3G mRNA的表达量均明显高于健康对照组( Z=-6.306和-6.280,P<0.01)和HCV单一感染组(Z=-7.358和-7.275,P<0.01)。 HIV单一感染组、HIV/HCV合并感染组、HCV单一感染组和健康对照组血浆中 IFN-α表达量分别为2.79(1.25),2.05(1.29),2.32(1.84)和2.16(2.19) pg/mL,其中 HIV 单一感染组血浆中 IFN-α表达量稍高于HIV/HCV合并感染组(Z=-2.332,P<0.05),其他各组血浆中IFN-α表达量比较差异均无统计学意义(P值均>0.05)。血浆中 IFN-α水平与 A3G mRNA 表达水平未见明显相关性(rs =0.04,P >0.05),A3G mRNA 及 IFN-α表达量与HIV 及 HCV RNA 载量亦无明显相关性(P 值均>0.05)。结论 HIV感染者PBMC高表达A3G,合并HCV感染对艾滋病患者的A3G表达无明显影响;A3G mRNA与IFN-α无明显相关性,且对HIV、HCV RNA载量的影响并不明显。 Objective To study the impact of HIV and hepatitis C virus ( HCV ) infection on peripheral expression of antiviral protein A3G and plasma IFN-αlevels.Methods Untreated patients with chronic hepatitis C(HCV infection group, n=43), AIDS(HIV infection group, CD4 +T〈200 cells/μL, n=45) and HIV/HCV co-infection (CD4 +T〈200 cells/μL, n=45) were recruited in the study, and 23 healthy subjects were also enrolled as controls.A3G mRNA in peripheral blood mononuclear cells (PBMC) was measured by quantificational real-time PCR, and plasma IFN-αlevel was determined by enzyme linked immunosorbent assay (ELISA).Rank-sum test and Spearman rank correlation analysis were performed. Results A3G mRNA levels in HIV infected group, HIV/HCV co-infected group, HCV infected group and healthy control group were 4.89 (0.59), 4.85 (0.71), 3.89 (1.08) and 3.69 (0.81) lg copies/mL, respectively.A3G mRNA levels in HIV infected group and HIV/HCV co-infected group were much higher than those in healthy control group (Z=-6.306 and -6.280, P〈0.01) and HCV infected group (Z=-7.358 and -7.275, P〉0.01).Plasma IFN-αlevels in HIV infected group, HIV/HCV co-infected group, HCV infected group and healthy control group were 2.79 (1.25), 2.05 (1.29), 2.32 (1.84) and 2.16 (2.19) pg/mL, respectively.Plasma level of IFN-αin HIV infected group was higher than that in the HIV/HCV co-infected group (Z=-2.332, P〉0.05), but no significant difference was observed among other groups (all P〈0.05).There was no significant correlation between plasma IFN-αlevel and A3G mRNA expression (rs =0.04, P〈0.05), and the levels of A3G mRNA and IFN-αshowed no correlation with HIV RNA and HCV RNA (all P〉0.05).Conclusions A3G is highly expressed in PBMCs from HIV infected patients, and it may not be affected by the infection of HCV.A3G mRNA is not closely correlated with IFN-α, and it has not significant influence on HIV RNA and HCV RNA replication.
出处 《中华临床感染病杂志》 CAS 2014年第6期494-499,共6页 Chinese Journal of Clinical Infectious Diseases
基金 “十二五”国家科技重大专项(2012ZX10001003) 国家自然科学基金(81201286) 广东省自然科学基金(10451006002006054)
关键词 HIV感染 肝炎 丙型 载脂蛋白B mRNA编辑酶催化多肽样蛋白3G 干扰素类 HIV Infections Hepatitis C Apolipoprotin B mRNA editing catalytic polypeptide 3 protein G Interferons
  • 相关文献

参考文献17

  • 1Sheehy AM, Gaddis NC, Choi JD, et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein[J]. Nature, 2002, 418:646-650.
  • 2Komohara Y, Yano H, Shichijo S, et al. High expression ot" APOBEC3G in patients infected with hepatitis C virus[J]. J Mol Histol, 2006,37:327-332.
  • 3Peng ZG, Zhao ZY, Li YP, et al. Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3(; is an innate defensive factor and drug target against hepatitis C virus [ J ]. Hepatology, 2011,53 : 1080 - 1089.
  • 4Turelli P, Mangeat B, Jost S, et al. Inhibition of hepatitis B virus replication by APOBEC3G[ J]. Science, 2004, 303:1829.
  • 5Albin JS, Harris RS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics [ J ].Expert Rev Mol Med, 2010, 12:e4.
  • 6Desimmie BA, Delviks-Frankenbela'ry KA, Burdick RC, et ah Multiple APOBEC3 restriction factors tbr HIV-1 and one Vif to rule them all[ J]. J Mol Biol, 2014, 426 : 1220-1245.
  • 7聂静敏,蔡卫平,胡凤玉,李凌华,刘金峰,许敏,关玉娟,唐小平.慢性丙型肝炎患者外周血单个核细胞中APOBEC3GmRNA与血丙型肝炎病毒RNA的相关性[J].中华传染病杂志,2011,39(2):104-107. 被引量:3
  • 8王爱霞,王福祥,毛青,等.艾滋病诊疗指南//中华医学会第五次全国艾滋病、病毒性丙型肝炎暨全国热带病学术会议[C].武汉,2011.
  • 9中华医学会肝病学分会;中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华肝脏病杂志,2004.12:7-11.
  • 10Puig-Kr:ger A, Sanz-Rodriguez F, Longo N, et al. Maturation- dependent expression and function of the CIM9d integrin on monocyte-derived human dendritic cells [ J]. J Immunol, 2000, 165:4338-4345.

二级参考文献16

  • 1Sheehy AM,Gaddis NC,Choi JD,et al.Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.Nature,2002,418:646-650.
  • 2Zhang H,Yang B,Pomerantz RJ,et al.The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.Nature,2003,424:94-98.
  • 3Mangeat B,Turelli P,Caron G,et al.Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.Nature,2003,424:99-103.
  • 4Mitrophanous K,Yoon S,Rohll J,et al.Stable gene transfer to the nervous system using a non-primate lentiviral vector.Gene Ther,1999,6:1808-1818.
  • 5Turelli P,Mangeat B,Jost S,et al.Inhibition of hepatitis B virus replication by APOBEC3G.Science,2004,303:1829.
  • 6Rosler C,Kock J,Malim MH,et al.Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".Science,2004,305:1403.
  • 7Suspène R,Guétard D,Henry M,et al.Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.Proc Natl Acad Sci USA,2005,102:8321-8326.
  • 8Yu Q,Konig R,Pillai S,et al.Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.Nat Struct Mol Biol,2004,11:435-442.
  • 9Harris RS,Bishop KN,Sheehy AM,et al.DNA deamination mediates innate immunity to retroviral infection.Cell,2003,113:803-809.
  • 10Newman EN,Holmes RK,Craig HM,et al.Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.Curr Biol,2005,15:166-170.

共引文献4

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部